Matthew D. Galsky

1. Treatment of muscle‐invasive and advanced bladder cancer in 2020
   2020/08/07 by Vaibhav G. Patel, William Oh, William K. Oh +1 · 27 citations
   Medicine · #Bioinformatics #Biology #Bladder and Urothelial Cancer Treatments #Bladder cancer #Cancer #Cancer Immunotherapy and Biomarkers #Cancer research #Drug #Drug development #Immunotherapy #Internal medicine #Medicine #Oncology #Pharmacology #Urinary and Genital Oncology Studies
2. Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274
   2024/10/11 by Matthew D. Galsky, J. Alfred Witjes, Jürgen E. Gschwend +19 · 1 voice · 1 citation
   Medicine · #Bladder and Urothelial Cancer Treatments #Urinary and Genital Oncology Studies #Cancer Immunotherapy and Biomarkers
3. PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
   2025/03/17 by Mansi Saxena, Thomas U. Marron, Julia Kodysh +34 · 1 voice · 2 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches